Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Biotechnologies · China · 2023-01-25

Processing Time
124 days
Decision Date
2023-01-25
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing state-of-the-art agonistic onco-immunologic approaches for therapeutic applications to progress next-generation tumor treatment, specifically targeting advanced and metastatic late-stage tumors. The work utilizes therapeutic cellular engineering and biologics techniques to improve cancer immunotherapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cancer, a leading cause of mortality, and impacts the U.S. pharmaceutical market.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 12 years of experience, a Ph.D., and a significant publication and citation record.

3 Waiver Benefit Met

On balance, the petitioner's specialized knowledge in cellular engineering and oncology makes his contributions beneficial to the U.S. without a labor certification.

Why This Petition Was Approved

The case was approved based on the petitioner's 15 peer-reviewed journal articles, one book chapter, and 361 citations demonstrating significant influence in the field. Additional evidence included 35 peer reviews for authoritative journals and two expert letters of support, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions

Similar Cases

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Research Scientist

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Oklahoma 33 days 2025-09-10
The petitioner proposes to develop advanced preclinical cancer models to evaluate the efficacy and immune responses of novel immunotherapies, including cancer vaccines and antibody-drug conjugates. This work focuses on optimizing rational combination strategies to improve clinical outcomes for patients with treatment-resistant and aggressive cancers. The endeavor aims to bridge the gap between laboratory discovery and clinical application to make therapies safer and more accessible.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-01-25.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 124 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist